These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23598723)

  • 1. Systemic BP and heart rate as prognostic indicators in pulmonary arterial hypertension.
    Bersohn MM; Turner MP; Traiger GL; Frost AE; Shapiro S
    Chest; 2013 Sep; 144(3):959-965. PubMed ID: 23598723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry.
    Barst RJ; Chung L; Zamanian RT; Turner M; McGoon MD
    Chest; 2013 Jul; 144(1):160-168. PubMed ID: 23429998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
    Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD
    Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL Registry analysis.
    Frost AE; Badesch DB; Miller DP; Benza RL; Meltzer LA; McGoon MD
    Chest; 2013 Nov; 144(5):1521-1529. PubMed ID: 23907471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis.
    Benza RL; Miller DP; Foreman AJ; Frost AE; Badesch DB; Benton WW; McGoon MD
    J Heart Lung Transplant; 2015 Mar; 34(3):356-61. PubMed ID: 25447572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-Year outcomes of patients enrolled in the REVEAL Registry.
    Farber HW; Miller DP; Poms AD; Badesch DB; Frost AE; Muros-Le Rouzic E; Romero AJ; Benton WW; Elliott CG; McGoon MD; Benza RL
    Chest; 2015 Oct; 148(4):1043-54. PubMed ID: 26066077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portopulmonary hypertension: a report from the US-based REVEAL Registry.
    Krowka MJ; Miller DP; Barst RJ; Taichman D; Dweik RA; Badesch DB; McGoon MD
    Chest; 2012 Apr; 141(4):906-915. PubMed ID: 21778257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
    Barst RJ; McGoon MD; Elliott CG; Foreman AJ; Miller DP; Ivy DD
    Circulation; 2012 Jan; 125(1):113-22. PubMed ID: 22086881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
    Shapiro S; Traiger GL; Turner M; McGoon MD; Wason P; Barst RJ
    Chest; 2012 Feb; 141(2):363-373. PubMed ID: 21757572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of first-time hospitalizations in patients with newly diagnosed pulmonary arterial hypertension in the REVEAL registry.
    Burger CD; Long PK; Shah MR; McGoon MD; Miller DP; Romero AJ; Benton WW; Safford RE
    Chest; 2014 Nov; 146(5):1263-1273. PubMed ID: 24901386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis.
    Poms AD; Turner M; Farber HW; Meltzer LA; McGoon MD
    Chest; 2013 Jul; 144(1):169-176. PubMed ID: 23348820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of systolic blood pressure and resting heart rate with clinical outcomes in takotsubo syndrome: insights from the International Takotsubo Registry.
    Böhm M; Cammann VL; Ghadri JR; Ukena C; Gili S; Di Vece D; Kato K; Ding KJ; Szawan KA; Micek J; Jurisic S; D'Ascenzo F; Frangieh AH; Rechsteiner D; Seifert B; Ruschitzka F; Lüscher T; Templin C;
    Eur J Heart Fail; 2018 Jun; 20(6):1021-1030. PubMed ID: 29517122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining heart rate and systolic blood pressure to improve risk stratification in older patients with heart failure: Findings from the RICA Registry.
    Sánchez-Gil J; Manzano L; Flather M; Formiga F; Martel AC; Molinero AM; López RQ; Jiménez JL; Iborra PL; Perez-Calvo JI; Montero-Pérez-Barquero M;
    Int J Cardiol; 2017 Mar; 230():625-629. PubMed ID: 28063667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL).
    Preston IR; Roberts KE; Miller DP; Sen GP; Selej M; Benton WW; Hill NS; Farber HW
    Circulation; 2015 Dec; 132(25):2403-11. PubMed ID: 26510696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry.
    Frantz RP; Farber HW; Badesch DB; Elliott CG; Frost AE; McGoon MD; Zhao C; Mink DR; Selej M; Benza RL
    Chest; 2018 Jul; 154(1):126-135. PubMed ID: 29355551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry.
    Chung L; Farber HW; Benza R; Miller DP; Parsons L; Hassoun PM; McGoon M; Nicolls MR; Zamanian RT
    Chest; 2014 Dec; 146(6):1494-1504. PubMed ID: 24992469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.
    Benza RL; Miller DP; Barst RJ; Badesch DB; Frost AE; McGoon MD
    Chest; 2012 Aug; 142(2):448-456. PubMed ID: 22281797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk.
    Böhm M; Schumacher H; Leong D; Mancia G; Unger T; Schmieder R; Custodis F; Diener HC; Laufs U; Lonn E; Sliwa K; Teo K; Fagard R; Redon J; Sleight P; Anderson C; O'Donnell M; Yusuf S
    Hypertension; 2015 Mar; 65(3):651-61. PubMed ID: 25583157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
    Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
    Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mm Hg: insights from the REVEAL Registry.
    Frost AE; Farber HW; Barst RJ; Miller DP; Elliott CG; McGoon MD
    Chest; 2013 Jan; 143(1):185-195. PubMed ID: 22661451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.